Joaquín Martínez-López

9PUBLICATIONS
50CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursDiagnostic radiographyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Oct 31, 2025
Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis.

Alberto Blanco-Sánchez, Rosa Ayala, Gonzalo Carreño-Tarragona

|May 26, 2025
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients.

Sjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven

|Aug 21, 2023
Regulation of miRNA expression by α4β1 integrin-dependent multiple myeloma cell adhesion.

Yaiza Rodríguez-García, Mónica Martínez-Moreno, Lola Alonso

|May 19, 2023
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study.

Rosa Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez

|Jul 18, 2022
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib.

Paul G Richardson, Arnon Nagler, Dina Ben-Yehuda

Pageof 2

Frequent Collaborators

4 joint publications

Rosa Ayala Diaz

2 joint publications

Rafael Alonso Fernández

1 joint publications

Sjoerd J F Hermans

1 joint publications

Thomas Pabst